This inventor holds 1 USPTO granted patent. Top assignee: Bio-Thera Solutions, Ltd., Co.. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Inventor Shenfeng Li and his Contributions to Targeted Cancer Therapy
Introduction: Shenfeng Li, a talented inventor based in Belmont, California, has made significant strides in the field of targeted cancer therapy. With a focus on innovative drug delivery systems, his work aims to improve treatment efficacy for patients with antigen-positive cancers and immunological disorders.
Latest Patents: Shenfeng Li holds one patent for his invention of maytansinoid derivatives. This patent, titled "Maytansinoid Derivatives," discloses novel drug linker derivatives that can be effectively linked to an antigen binding unit (Abu). The invention includes maytansinoid drugs that are linked with this antigen binding unit, referred to as Drug-Linker-Antigen Binding Unit (D-L-Abu). These innovative drug conjugates have been designed to facilitate targeted drug delivery to disease tissues, enhancing treatment outcomes for patients suffering from specific medical conditions.
Career Highlights: As an integral part of Bio-Thera Solutions, Ltd., Shenfeng Li has contributed to the advancement of biopharmaceuticals. His career is marked by a deep commitment to research and development, specifically targeting therapeutic solutions for challenging diseases. Li’s patent showcases his innovative thinking and commitment to improving patient outcomes through advanced therapeutic methods.
Collaborations: During his time at Bio-Thera Solutions, Ltd., Shenfeng Li has worked alongside esteemed colleagues such as Xiaobin Deng and Songnuan Tan. These collaborations have allowed for a dynamic exchange of ideas and have played a crucial role in driving forward their shared mission of enhancing cancer treatment modalities.
Conclusion: Shenfeng Li’s contributions to the field of targeted cancer therapy through his innovative maytansinoid derivatives demonstrate his expertise and dedication as an inventor. His ongoing work at Bio-Thera Solutions, Ltd., coupled with valuable collaborations, positions him as a key player in the advancement of medical treatments, paving the way for future innovations in oncology and immunology.